Digital disruption in healthcare has created an opportunity for new products that are data-driven and patient-centered. The market volume of medical technology by 2026 is estimated to reach USD 644.2 billion (Source: Statista). However, bringing a medical device or drug to market is very different from building other kinds of products. Strict regulation also makes it a highly complex process. The MIT xPRO Drug and Medical Device Development: A Strategic Approach program is designed to provide you with a big picture view of initiating a medical drug or product development. It will also help you anticipate and address the complexities involved with developing medical products.